Reverse HER2-negative Immune Resistant Breast Cancer

Clinical trial NCT06731140 · RECRUITING

Trial details

NCT number: NCT06731140
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HER2 Negative Breast Cancer

Start date: 2025-02-12
Primary completion: 2026-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.